These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 25701793

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.
    Li YQ, Lu JH, Bao XM, Wang XF, Wu JH, Hong WQ.
    J Exp Clin Cancer Res; 2015 Oct 26; 34():130. PubMed ID: 26503504
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.
    Li YQ, Ren XY, He QM, Xu YF, Tang XR, Sun Y, Zeng MS, Kang TB, Liu N, Ma J.
    Cell Death Dis; 2015 Jan 22; 6(1):e1618. PubMed ID: 25611392
    [Abstract] [Full Text] [Related]

  • 7. miR-1, regulated by LMP1, suppresses tumour growth and metastasis by targeting K-ras in nasopharyngeal carcinoma.
    Chen X, Shi J, Zhong J, Huang Z, Luo X, Huang Y, Feng S, Shao J, Liu D.
    Int J Exp Pathol; 2015 Dec 22; 96(6):427-32. PubMed ID: 26852690
    [Abstract] [Full Text] [Related]

  • 8. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma.
    Luo Z, Zhang L, Li Z, Li X, Li G, Yu H, Jiang C, Dai Y, Guo X, Xiang J, Li G.
    BMC Med Genomics; 2012 Jan 19; 5():3. PubMed ID: 22260379
    [Abstract] [Full Text] [Related]

  • 9. miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways.
    He Q, Ren X, Chen J, Li Y, Tang X, Wen X, Yang X, Zhang J, Wang Y, Ma J, Liu N.
    Oncotarget; 2016 Jan 19; 7(3):3047-58. PubMed ID: 26655091
    [Abstract] [Full Text] [Related]

  • 10. The effects of microRNA-98 inhibits cell proliferation and invasion by targeting STAT3 in nasopharyngeal carcinoma.
    Liu J, Chen W, Chen Z, Wen J, Yu H, Wang F, Wu L, He X.
    Biomed Pharmacother; 2017 Sep 19; 93():869-878. PubMed ID: 28724212
    [Abstract] [Full Text] [Related]

  • 11. The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L.
    Wang S, Mo Y, Midorikawa K, Zhang Z, Huang G, Ma N, Zhao W, Hiraku Y, Oikawa S, Murata M.
    Oncotarget; 2015 Nov 03; 6(34):35893-907. PubMed ID: 26486082
    [Abstract] [Full Text] [Related]

  • 12. MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma.
    Yi C, Wang Q, Wang L, Huang Y, Li L, Liu L, Zhou X, Xie G, Kang T, Wang H, Zeng M, Ma J, Zeng Y, Yun JP.
    Oncogene; 2012 Oct 11; 31(41):4421-33. PubMed ID: 22249270
    [Abstract] [Full Text] [Related]

  • 13. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
    Cui Z, Zhao Y.
    BMC Cancer; 2019 Jan 24; 19(1):104. PubMed ID: 30678643
    [Abstract] [Full Text] [Related]

  • 14. MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21.
    Chen C, Lu Z, Yang J, Hao W, Qin Y, Wang H, Xie C, Xie R.
    Cancer Med; 2016 Dec 24; 5(12):3489-3499. PubMed ID: 27774777
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression.
    Yu BL, Peng XH, Zhao FP, Liu X, Lu J, Wang L, Li G, Chen HH, Li XP.
    Int J Oncol; 2014 Apr 24; 44(4):1215-22. PubMed ID: 24481647
    [Abstract] [Full Text] [Related]

  • 16. An integrative transcriptomic analysis reveals p53 regulated miRNA, mRNA, and lncRNA networks in nasopharyngeal carcinoma.
    Gong Z, Yang Q, Zeng Z, Zhang W, Li X, Zu X, Deng H, Chen P, Liao Q, Xiang B, Zhou M, Li X, Li Y, Xiong W, Li G.
    Tumour Biol; 2016 Mar 24; 37(3):3683-95. PubMed ID: 26462838
    [Abstract] [Full Text] [Related]

  • 17. CircHIPK3 promotes proliferation and invasion in nasopharyngeal carcinoma by abrogating miR-4288-induced ELF3 inhibition.
    Ke Z, Xie F, Zheng C, Chen D.
    J Cell Physiol; 2019 Feb 24; 234(2):1699-1706. PubMed ID: 30070690
    [Abstract] [Full Text] [Related]

  • 18. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
    Jiang N, Jiang X, Chen Z, Song X, Wu L, Zong D, Song D, Yin L, Wang D, Chen C, Bian X, He X.
    J Exp Clin Cancer Res; 2017 Oct 05; 36(1):138. PubMed ID: 28982387
    [Abstract] [Full Text] [Related]

  • 19. miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma.
    Liu Y, Zhao R, Wang H, Luo Y, Wang X, Niu W, Zhou Y, Wen Q, Fan S, Li X, Xiong W, Ma J, Li X, Tan M, Li G, Zhou M.
    Cell Death Dis; 2016 Mar 24; 7(3):e2156. PubMed ID: 27010857
    [Abstract] [Full Text] [Related]

  • 20. MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway.
    Zheng Z, Qu JQ, Yi HM, Ye X, Huang W, Xiao T, Li JY, Wang YY, Feng J, Zhu JF, Lu SS, Yi H, Xiao ZQ.
    Cell Death Dis; 2017 Jun 01; 8(6):e2855. PubMed ID: 28569771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.